Date: 26 November 2013
Secondary metabolites, structure diagram: Trivial name – Aflatoxin B3
Copyright: n/a
Notes:
Species: A. (species not defined)Systematic name: 2H-Furo[3′,2′:4,5]furo[2,3-h]-1-benzopyran-2-one, 7a,10a-dihydro-4-(2-hydroxyethyl)-5-methoxy-Molecular formulae: C16H14O6Molecular weight: 302.279Chemical abstracts number: 23315-33-5Selected references: Metabolites of Aspergillus flavus. Heathcote, John G.; Dutton, M. F. Univ. Salford, Salford, UK. Tetrahedron (1969), 25(7), 1497-500. CODEN: TETRAB ISSN: 0040-4020. Journal written in English. CAN 70:103858 AN 1969:103858 CAPLUS
Images library
-
Title
Legend
-
Bronchoscopic manifestations of Aspergillus tracheobronchitis. (a) Type I. Inflammatory infiltration, mucosa hyperaemia and plaques of pseudomembrane formation in the lumen without obvious airway occlusion. (b) Type II. Deep ulceration of the bronchial wall. (c) Type III. Significant airway occlusion by thick mucous plugs full of Aspergillus without definite deeper tissue invasion. (d) Type IV. Extensive tissue necrosis and pseudomembrane formation in the lumen with airway structures and severe airway occlusion (Wu 2010).
-
High resolution CT showing centrilobular nodular opacities and branching linear opacities (tree-in-bud appearance) (Al-Alawi 2007).
-
Chest X-ray showing poorly defined bilateral nodular opacities (Al-Alawi 2007).
-
Gross pathologic specimen from autopsy shows the bronchial lumen covered by multiple whitish endobronchial nodules (arrows) (Franquet 2002).
-
Invasive tracheobronchitis showing numerous nodules seen during bronchoscopy (Ronan D’Driscoll).
-
Pseudomembranous seen overlying the bronchial mucosa (Tasci 2006).
